| dc.contributor.author | Farah, B M | |
| dc.contributor.author | Ogola, S | |
| dc.contributor.author | Indangasi, J | |
| dc.contributor.author | Oyaro, M | |
| dc.contributor.author | Anzala, O | |
| dc.contributor.author | Omosa-Manyonyi, G | |
| dc.contributor.author | Jaoko, W | |
| dc.contributor.author | Gillmour, J | |
| dc.contributor.author | Bwayo, J | |
| dc.contributor.author | 1Kavi, Nairobi, Kenya; 2Iavi, New York, United State | |
| dc.date.accessioned | 2013-06-23T10:51:06Z | |
| dc.date.available | 2013-06-23T10:51:06Z | |
| dc.date.issued | 2004 | |
| dc.identifier.citation | B M Farah , , et al. The use of viral peptides as a quality control for ELISPOT assays in HIV-1 vaccine trials in Kenya . CD Only: The XV International AIDS Conference: Abstract no. A10065" | en |
| dc.identifier.uri | http://hdl.handle.net/11295/38503 | |
| dc.description.abstract | Abstract no. A10065" | en |
| dc.language.iso | en | en |
| dc.publisher | University of Nairobi, | en |
| dc.title | The Use of Viral Peptides as a Quality Control for ELISPOT Assays in HIV-1 Vaccine Trials in Kenya | en |
| dc.type | Presentation | en |
| local.publisher | College of Health Sciences, | en |
